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Abstract 
Background: Despite the general concern about the safety of blood 
transfusion and mounting evidence exist for more restrictive practice; there is 
no national consensus guideline and uniformity of institutions for blood 
transfusion associated with coronary artery bypass graft surgery in Iran. The 
aim of this study is an assessment of current transfusion practice and 
compares it with one decade ago.  
Materials and Methods: The authors retrospectively analyzed the data of all 
patients undergoing elective surgery (first time operation) during one year, in 
two different decade interval (2003 and 2015) in a tertiary heart center.  
Results: A total of 801 patients were evaluated and compared (n=249 in 
2015, n=552 in 2003). There is a significant increase in the use of blood 
transfusion in both operating room and at ICU than the last decade (60.6% 
vs. 42.4%, p<0.001, and 54.4% vs. 39.9%, p <0.001, respectively). The 
incidence of preoperative anemia was four times higher in patients who 
received transfusion, compared to those who did not, in both groups. With 
compared to the past, the patients are older, have less preoperative 
hematocrit, more diabetic, more need to intra-aortic balloon pump, shorter 
operation time, and less postoperative bleeding.  
Conclusion: With advanced knowledge about transfusion complications and 
conservative approach to transfusion practice, the need to blood transfusion is 
increased in current cardiac operations in our center, due to association of 
more co-morbidity.  
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Introduction 
The growing evidence indicating inevitable blood 
transfusion during cardiac surgery is dose dependent 
and associated with increase morbidity and mortality. 
In addition to systemic inflammatory response due to 
cardiopulmonary bypass, leukocyte containing blood 
transfusion induces immune modulation, stimulates to 
release more inflammatory cytokines (IL6, IL12, 
TNFα) and procalcitonin, and lower level of anti- 
inflammatory marker like IL10. Any effort to reduce 
blood products are valuable (1-6).  
 The presence and synergistic effect of 
constant factors such as: acute hemodilution, the 
complexity of the cardiac surgeries and patients 
factors (comorbidities, preoperative anemia, age, 
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small body size, female gender and non-elective 
surgery) may explain high rate of blood transfusion 
during cardiac surgery (1, 2, 7).  
Preoperative anemia, blood loss, and nadir of 
hematocrit (Hct) are risk factors of perioperative 
blood transfusion (2, 5). Although blood transfusion 
is often life-saving, but there is a growing body of 
evidence suggests an association between blood 
transfusion and increased morbidity, mortality, waste 
of resources, in addition to significant cost (4, 8-11). 
Several pharmacological agents and mechanical 
methods in the perioperative setting have been 
introduced to reduce perioperative transfusion, but the 
lower safe limit of hematocrit (Hct) in cardiac surgery 
patients was not described.  
The objective of present study was to explain 
the transfusion management and physicians practice 
during one decade in a tertiary cardiac center in Iran 
and its comparison with other countries. 
Methods 
The surgical and anesthetic procedures were 
same during this decade. Standard monitoring was 
instituted before surgery (arterial pressure, central 
venous pressure, electrocardiogram, urinary catheter 
and nasal temperature). The surgical staffs were the 
same during the study period. 
Study Population 
The study was designed as a retrospective 
cross-sectional study in a tertiary educational referral 
hospital in Tehran, Iran. Patients who underwent 
elective primary coronary artery bypass grafting 
(CABG) using cardiopulmonary bypass (CPB) in 
2003 and 2015 (one decade interval) were studied 
based on inclusion and exclusion criteria. All other 
types of cardiac procedures, off-pump CABG, 
combination of CABG with other cardiac surgeries 
and preoperative blood transfusion were excluded. 
The Research Ethics Committee approved the use of 
anonymous data and the need for individual patient 
consent form was waived.  
Data Collection 
The authors performed a retrospective review 
of prospectively collected data. All demographic, 
clinical and paraclinical date, laboratory findings, 
cardiovascular risk factors such as, hypertension, 
smoking, diabetes mellitus, previous myocardial 
infarction, operative details (time of CPB and aortic 
clamp, the number of grafted vessels, need to intra-
aortic balloon pump (IABP), exploration for 
bleeding), 30-days survival and transfusion therapy 
were collected.  
Transfusion Guideline 
Hct level was measured at preoperative 
admission, after arterial line placement, 10 minutes 
after initiation of CPB, every 30 minutes during CPB, 
before termination of CPB, and every 30 min. after 
CPB in the operating room, upon arrival and every 
four hours in the ICU from the first day after surgery 
(and more frequently in bleeding, or unstable 
patients). Except to life-threatening bleeding, an 
absolute indication for blood transfusion, transfusion 
decision was based on Hct and was constant during 
this decade: an Hct level of 20–22% during CPB. 
After CPB weaning and return of remained blood, 
patients were transfused for Hct ≤27%. The Hct 
threshold for blood transfusion was 26–28% in the 
ICU. If the patient's status showing signs of 
hemodynamic instability, or excessive bleeding, the 
cardiac intensivists could administer blood 
transfusion outside this policy. However, blood 
transfusion was not allowed for an Hct 30%, or 
greater. When blood was ordered for transfusion, the 
blood bank provided the oldest available matching 
unit for each request. Leucodepletion has not been 
used for transfused blood.  
Return to operating room was considered, if 
the patient had sustained hemodynamic instability not 
responding to an intravenous fluid with increasing 
requirement for inotropic support in the setting of 
excessive chest bleeding. The transfusion protocol 
was followed by all care givers. 
Statistical Analysis 
Dichotomous and categorical variables were 
presented as percentages and were tested by the Chi-
square test. Continuous variables were expressed as 
mean±SD and one way analysis of variance was 
performed to compare the means among the groups. 
Statistical analyses were performed using SPSS 
version 12.0 (SPSS Inc, Chicago, Illinois) and P<0.05 
was considered statistically significant. 
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Results 
Study Population 
Based on our criteria, 801 adult patients who 
had undergone CABG (n= 552 in 2003 and n=249 in 
2015) were eligible for the study and 66 patients were 
excluded due to incomplete data record. Preoperative 
demographic characteristics, intraoperative data and 
postoperative variables are summarized in Tables1and 
2 respectively.  
Baseline Hct concentration showed a 
significant decrease during this interval. The 
prevalence of anemia (according to WHO definition 
cutoff values for women: 12 g/L and men: 13 g/L) 
had increased significantly from 17.9% in 2003 to 
31.6% in 2015 (p=0.00), with no gender tendency. 
The incidence of preoperative anemia was four times 
higher in patients, who received transfusion compared 
to those who did not, in both groups (3.7% vs. 18.2%, 
p= 0.00).  
Duration of surgery and CPB time and 
excessive postoperative hemorrhage need to 
exploration in patients of 2015 were significantly less 
than patients of 2003 (table 2). There was a 
significant decrease in the total number of distal 
grafts, but it does not seem clinically different. There 
were no differences between the groups in 
mediastinal drainage and length of ICU and hospital 
stay. Hospital mortality had not significant 
differences between the groups. There were no 
Table 1: Preoperative demographic data of patients. 
 
Groups 2015 (N=249) 2003 (N=552) P value 
   Male (%) 190 (76.3%) 387 (70.1%) 0.07 
   Age (years) 60.7± 9.3 59± 9.9 0.02* 
   Hyperlipidemia (%) 90 (37.3%) 246 (44.6%) 0.06 
   Hypertension (%) 133 (53.6%) 269 (48.8%) 0.2 
   Diabetes mellitus (%) 91 (37%) 160 (29%) 0.02* 
   Family history for CABG (%) 43 (18.1%) 108 (19.6%) 0.6 
   Anemia (%) 78 (31.6%) 98 (17.9%) 0.000* 
   Active smoking (%) 86 (35.1%) 189 (34.2%) 0.8 
   Myocardial infarction (%) 76(30.8%) 139 (25.2%) 0.1 
   Blood Urea Nitrogen (mg/dL)           40.2±19 22±11.1 0.000* 
   Creatinine (mg/dL) 1.2±0.7 1.2±0.5 0.6 
   Fasting blood sugar (mg/dL) 134±65 120±54 0.001* 
  Hematocrit (%) 40±4.7 41.8±4.8 0.000* 
  β blockers (%) 202 (83.1%) 354 (64%) 0.000* 
  Aspirin (%) 181 (73.3%) 117 (21.7%) 0.000* 
  ACEI (%) 168 (68%) 302 (56%) 0.002* 
  Diuretics (%) 52 (20.9%) 78 (14.5%) 0.03* 
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intraoperative deaths in either group. Preoperative 
withdrawal of autologous blood is not performed due 
to anemia and short hospital-stay before operation. 
Transfusion 
Intra-and postoperative blood transfusion data 
are shown in Table 3. While the incidence of 
transfusion was increasing from 42.4% in 2003 to 
62% in 2015, the blood units administered per patient 
also increased from a mean of 0.5 units in 2003 to 1.2 
units in 2015. In 2003 group, a total number of 755 
units of packed red blood cell were used for 
transfusion, 324 units were transfused during 
operation and 431 units in the postoperative period. 
This data had increased to 602 and 316, respectively, 
in 2015 group. 
The significant association between female 
gender and increased need to transfusion was only 
seen in 2003 group during operation (male/female: 
33.5% vs. 63.4%, p=0.000). Table 4 shows gender 
differences in blood transfusion requirement and 
anemia prevalence. There were no association 
between coexisting diseases and patients, who were 
treated with blood transfusion.  
Group differences according to transfusion 
Left ventricular ejection fraction was 
comparable in patients who received blood 
transfusion and who did not in both groups. Patients 
who received perioperative blood transfusions had 
more distal anastomoses than patients who did not in 
2003 group (p= 0.02) with no significant difference in 
2015 group (p=0.3). The duration of CPB had a 
significant effect on the magnitude of blood 
transfusion (p=0.006). Chest tube drainage has no 
important difference between the groups. According 
to WHO definition of anemia, it had increased 
prevalence in both genders during this decade. The 
Table 2: Operative and postoperative data. 
 
Groups 2015 (N=249) 2003 (N=552) P Value 
Ejection Fraction (%) 45.3±10.7 46.4±10.6 0.1 
Graft  number 3.1±0.7 3.4±0.8 0.000* 
Clamp time(minute) 59.5±18.9 68.5±18.5 0.000* 
Pump time(minute) 105.8±29.3 113.4±30.7 0.001* 
IABP (%) 35(14.7%) 31(5.6%) 0.000* 
Bleeding (%) 9 (3.7%) 78 (14.1%) 0.000* 
Hospital mortality (%) 6 (2.4%) 8 (1.4%) 0.3 
 
 Table 3: Intra and postoperative blood transfusion data. 
 
 2015 (N=249) 2003 (N=552) P value 
 Operative transfused packed cell (%) 152(62%) 233(42.4%) 0.000* 
 Operative transfused packed  cell(mean)     1.2±1.3 0.5±0.7 0.000* 
 ICU transfused packed cell(mean) 1.1±1.5 0.7±1.3 0.001* 
 ICU transfused packed cell (%) 218 (29.9%) 134 (54.5%) 0.000* 
Totally blood transfusion( intra and postoperative 
transfusion) 
195(80.6%) 350(64.5%) 
 
0.000* 
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incidence of re-exploration (in most cases for 
excessive bleeding) is much higher in patients 
receiving more blood. 
Discussion 
There was a significant increase in the use of 
blood transfusion during coronary surgery in a tertiary 
heart center after one decade, despite increasing 
evidence suggesting potential adverse events of blood 
transfusion. The patients of 2015 group were older 
with more co-morbidity such as diabetes and anemia. 
The management of coronary artery disease was 
changed during this interval. The operation time get 
shorter than the past with less exploration for bleeding 
with no increase in hospital death in the presence of 
more co-morbidity.  
The prevalence of CABG is decreased to <50% 
due to introduced percutaneous intervention methods, 
less invasive treatment options, and fewer surgery 
recommendation. 
Our center does not have limitation of blood 
transfusion resources and transfusion is free of charge 
for patients and hospitals in Iran. The government 
pays all the cost, without contribution from hospitals, 
reassurances and patients. There is less concern of 
blood supply issues for our relative young population 
in comparison with old-age population in other 
countries (14).  
There was a universal concept of improved 
cardiac output and oxygen delivery by blood 
transfusion (2, 3, 6, 15) and usually physicians notice 
Hct threshold during perioperative blood loss without 
notice clinical symptoms. It seems fear from 
detrimental physiologic effects of severe anemia may 
be responsible for inappropriate high-transfusion rate. 
A lot of studies confirmed even in critical care and 
cardiac surgery patients the restrictive strategy 
(transfusion threshold with Hb<7gr/dl) is as safe as 
liberal strategy with no more adverse outcome (2, 16-
17). 
There is an increasing evidence that relying on 
a single parameter without clinical signs of acute 
anemia, or oxygen deprivation (such as, tachycardia, 
hypotension, high oxygen-extraction ratio, low mixed 
venous oxygen saturation, and echocardiographic 
guided indices) may not be accurate for blood 
transfusion (2-4, 6, 8, 14, 16). There is a common 
conclusion in all of them: the less blood transfusion is 
better. Why does not it happen in practice? 
The higher morbidities of patients with cardiac 
surgery and the complexity of the procedure augment 
this disparity (4, 5, 13, 16-21) which is even present 
in results of dose dependent relationship between 
transfusion units and morbidity/mortality (2, 8, 11-13, 
17, 18, 22-24). The discrepancy is true for duration of 
storage blood and adverse outcome after cardiac 
surgery too (11, 13, 25-27). The published results of a 
study in more than 5000 cardiac surgery patients in 72 
Table 4: Sex differences in need to blood transfusion. 
 
variable gender 2015 (n=249) 2003(n=552) P value 
Intraoperative 
 transfusion 
 
Male 
58.6% 33.5% 0.00 
Female 72.9% 63.4% 0.18 
ICU transfusion 
 
Male 
52.7% 37.7% 0.04 
Female 60.3% 45.1% 0.00 
Anemia (%) 
 
 
Male 
23.9% 13.3% 0.001 
Female 7.7% 4.6% 0.007 
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centers among 16 countries showed the rate of blood 
transfusion was 9–100% in intraoperative period, and 
25-87% in postoperative period during 1996–2000 
(14). The significant differences in transfusion 
practice were observed in different countries and 
between centers of each country. It was reported 
according to American College of Physicians 
Transfusion Guidelines, 76% of transfusions were 
deemed to be inappropriate. They found US patients 
are much more likely to receive blood, despite having 
similar rates of anemia and bleeding to non-US study 
populations with no better outcomes (28). 
In a similar designed study, an observational 
cohort of 102470 patients with inclusion criteria of 
our study in 2008 at 798 cardiac centers in the US 
showed the blood transfusion rate was 56.1% (7.8– 
92.8%). They found that more use of blood 
transfusion at academic hospitals and those in lowest 
quartile of surgery volume (<115 operation/year) (9). 
In a comparable study on 3,374 CABG operations in 
25 cardiac centers in UK (68% of UK adult cardiac 
surgery centers), the mean use of packed cell was 
2.98 units (range 0–32) in 2010. Only 12% of cardiac 
centers had protocol for optimization of preoperative 
Hct before elective cardiac surgery (11). Straten et al. 
studied the data of more than 10,000 isolated CABG 
during 10 years; one third of them had transfusion 
(18). 
The lowest safe limit of Hct level, where the 
benefits of transfusion outweigh the risks is unknown. 
The authors believe the main cause in failure to 
achieve a consensus about transfusion during cardiac 
surgery is the presence of numerous studies with 
opposite results. The known responsible factors are 
preoperative characteristics of patients, operative 
characteristics, hospital factors and surgeons’ 
hemostatic practices. Attention to these aspects may 
help to identify patients at a high risk for transfusion 
and facilitate optimization leading to reduced 
perioperative blood transfusion (2, 6, 9, 13, 18, 22, 
29-31).  
It is presumed that the most important 
parameter is physician education to accept and 
believe in practice that restrictive transfusion strategy 
is safe and possibly more beneficial. It is the time to 
change the current practice behavior and accept 
permissive anemia, and make transfusion decisions 
based on clinical assessment of evidence of ischemia.  
Both preoperative anemia and blood 
transfusion are associated with adverse outcomes. 
Today patients with more illnesses are undergoing 
cardiac surgery with more need to transfusion. It 
makes difficult to assess a cause and effect 
relationship between transfusion and outcome, as it 
may be secondary to the transfusion indication and 
not the blood itself (1, 2, 8, 32-34). It was suggested 
preoperative anemia in patients with higher 
comorbidities are less tolerated (30, 35). 
The different dogmas persist in the field of 
ischemic heart disease. It was thought that these 
patients were less tolerant to anemia, due to decreased 
oxygen delivery to myocardium (36). The aim of 
blood transfusion is to restore adequate tissue oxygen 
delivery (13). It has been observed that blood 
transfusion in cardiac surgery increases oxygen 
delivery, while oxygen consumption remains stable 
(15). Some of evidence showed despite augmenting 
oxygen transport capacity, the stored blood 
transfusion may not necessarily contribute to 
improvement in microcirculatory oxygenation, and 
even may cause tissue ischemia and organ 
dysfunction (13, 20, 21). Some studies suggested 
blood transfusion in the setting of acute coronary 
syndrome (ACS) was a risk factor for mortality and 
MI, while nadir hematocrit as low as 25% may be 
tolerated in otherwise stable patient with ACS (17, 
28).  
The relationship of Hct level to perioperative 
myocardial ischemia is not clear, since the balance of 
oxygen supply/demand during CPB is affected by 
dilutional anemia, reduced vascular resistance, and 
increased blood viscosity (37, 38). According to the 
recent STS guideline, hematocrit level as low as 20% 
is safe in cardiac surgery with CPB due to associated 
hypothermia and increased viscosity (2, 39). The 
studies had shown lower Hct than this threshold is 
associated with adverse outcome, and interruption of 
myocardial metabolism recovery in early 
postoperative period (16,19,23,35,37). 
The results of Austrian benchmark study 
confirmed 98% of all transfusions in surgical patients 
are secondary to pre-operative anemia, important 
surgical blood loss and refusal with a more restrictive 
hemoglobin threshold for transfusion (38). 
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In agreement with these findings, a study of 
14,259 cardiac surgical procedures (during 2006-
2010) used a multidisciplinary approach, with the aim 
of reduction in blood transfusion. The incidence of 
blood transfusion was decreased significantly with 
improvement in patients’ outcome (10). More other 
studies had the similar results with up to 75% 
reduction of unnecessary blood transfusion (6,13,40). 
This event was not happened at this Center, by 
increased rate of anemic patients, without 
preoperative anemia correction and doubt about 
restrictive transfusion safety. It may confirm 
unnecessary increased transfusion rate, potentially 
unnecessary cost and care, even if it is not deleterious. 
The findings should be considered in the 
context of the following limitations. Due to the nature 
of a database and its design, some important factors 
unavailable in this database included length of storage 
of the blood, the nature of preoperative anemia, and 
lack of blood leukodepletion in our study. 
The study is the first to compare blood 
transfusion practice, after one decade in cardiac 
surgery patients as single center experience. The 
selection criteria used and the design of the study 
resulted in a sample that is very likely to represent the 
transfusion practices of most academic hospitals in 
Iran. The findings of this study may have important 
clinical implications. The results will help to convince 
the medical community to adopt a positive attitude 
toward the practice of blood conservation in cardiac 
surgery; believe that tolerance of anemia is a safe 
strategy and emphasize to treat preoperative anemia 
(and delay of surgery if necessary), as physician 
practices are slow to change. 
Conclusion 
Re-evaluation of transfusion practice in 
patients of cardiac surgery is suggested due to safety 
concerns about stored blood. To reduce the need for 
blood transfusion during cardiac surgery, adopting 
restrictive strategy and evaluation of the patient’s 
clinical situation are the important factors. A protocol 
assessment of patients for preoperative optimization 
of Hct prior to elective cardiac surgery is suggested. It 
seems that blood conservation policy is a belief before 
being a mandatory protocol. 
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